NEXTBio Capital Management LP
Filing Date
Global Rank
#4,015
/ 8,603
▲ 677
· as of Mar 2026
Top Industry
Biotechnology
94.8%
3Y Alpha vs SPY
+78.0%
Period ended 3 months ago
Filed May 14, 2026 · 56d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+33.7%
SPY
+10.0%
Annualised alpha
+80.6%
Max drawdown
−18.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
24 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.8%
+1.7 pts
Top 5
48.9%
+2.8 pts
Top 10
71.0%
+1.0 pts
HHI
699
Diversified+44
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $215,369,990 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | +1,268,776 | 2,021,407 | $11,178,380 | |
| ZBIO | Zenas BioPharma, Inc. | +104,753 | 426,736 | $8,342,688 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +58,492 | 126,078 | $10,965,003 | |
| TERN | Terns Pharmaceuticals, Inc. | +53,344 | 604,534 | $31,871,032 | |
| GPCR | Structure Therapeutics Inc. | +38,796 | 133,239 | $6,422,119 | |
| COGT | Cogent Biosciences, Inc. | +35,369 | 131,188 | $5,049,426 | |
| IVA | Inventiva S.A. | +34,783 | 1,333,484 | $7,400,836 | |
| ZLAB | Zai Lab Ltd | +20,000 | 183,362 | $3,449,039 | |
| IRON | Disc Medicine, Inc. | +9,877 | 52,655 | $3,366,760 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −265,801 | 848,204 | $4,486,999 | |
| ORIC | Oric Pharmaceuticals, Inc. | −92,101 | 523,619 | $6,634,252 | |
| EVMN | Evommune, Inc. | −44,223 | 184,063 | $4,231,608 | |
| VSTM | Verastem, Inc. | −530 | 1,306,800 | $6,926,040 | |
| XENE | Xenon Pharmaceuticals Inc. | −479 | 183,225 | $10,654,533 | |
| PCVX | Vaxcyte, Inc. | −262 | 95,223 | $5,533,408 | |
| OCS | Oculis Holding AG | −158 | 149,592 | $3,977,651 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | 89,717 | $1,701,034 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
24 positions ·
$215,369,990 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 604,534 | $31,871,032 | 14.80% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 229,619 | $24,201,842 | 11.24% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Held | 3,149,907 | $20,253,902 | 9.40% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 999,967 | $17,839,411 | 8.28% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 2,021,407 | $11,178,380 | 5.19% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 126,078 | $10,965,003 | 5.09% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 183,225 | $10,654,533 | 4.95% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Held | 82,686 | $10,306,809 | 4.79% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Added | 426,736 | $8,342,688 | 3.87% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 1,333,484 | $7,400,836 | 3.44% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Reduced | 1,306,800 | $6,926,040 | 3.22% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 372,856 | $6,849,364 | 3.18% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 523,619 | $6,634,252 | 3.08% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 133,239 | $6,422,119 | 2.98% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 95,223 | $5,533,408 | 2.57% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 131,188 | $5,049,426 | 2.34% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 848,204 | $4,486,999 | 2.08% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Reduced | 184,063 | $4,231,608 | 1.96% | |
| OCS |
Oculis Holding AG
Healthcare
|
Reduced | 149,592 | $3,977,651 | 1.85% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 183,362 | $3,449,039 | 1.60% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 52,655 | $3,366,760 | 1.56% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Held | 131,796 | $2,653,053 | 1.23% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
NEW | 89,717 | $1,701,034 | 0.79% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 157,827 | $1,074,801 | 0.50% |